Clinical Trial Update: Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

View source ↗

Summary

The clinical trial NCT04533919 has been withdrawn. It involved validation of pre-clinical nano-based analgesics in cells from human dorsal root ganglia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Neoplasms

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Spinal Cord Neoplasm | Status: WITHDRAWN